Reports- Vinpocetine Market | Page 3

1.4.1 California Status and Prospect (2012-2022) 1.4.2 Texas Status and Prospect (2012-2022) 1.4.3 New York Status and Prospect (2012-2022) 1.4.4 Florida Status and Prospect (2012-2022) 1.4.5 Illinois Status and Prospect (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Gedeon Richter 2.1.1 Profile 2.1.2 Vinpocetine Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Gedeon Richter Vinpocetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.4 Business Overview 2.1.5 Gedeon Richter News 2.2 Runhong 2.2.1 Profile 2.2.2 Vinpocetine Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Runhong Vinpocetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.4 Business Overview 2.2.5 Runhong News 2.3 Sun Pharma 2.3.1 Profile 2.3.2 Vinpocetine Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Sun Pharma Vinpocetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.4 Business Overview 2.3.5 Sun Pharma News 2.4 WZT 2.4.1 Profile 2.4.2 Vinpocetine Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 WZT Vinpocetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.4 Business Overview 2.4.5 WZT News 2.5 PUDE 2.5.1 Profile 2.5.2 Vinpocetine Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 PUDE Vinpocetine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.4 Business Overview